LongGMABAug 2026
Genmab A/S
Genmab is a vertically integrated pharmaceutical company specialising in antibody therapeutics for cancer. Better-than-expected second-quarter results were supported by continued…
GMAB
2 published ideas on Genmab A/S across 1 fund — 2 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Genmab A/S: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Genmab is a vertically integrated pharmaceutical company specialising in antibody therapeutics for cancer. Better-than-expected second-quarter results were supported by continued…
Genmab is a vertically integrated pharmaceutical company specialising in antibody therapeutics for cancer. Better-than-expected second-quarter results were supported by continued…